QID 375840

Date Published: 2021-09-09

QID 375840: Zoho ManageEngine ADSelfService Plus Remote Code Execution Vulnerability

ManageEngine ADSelfService Plus is a secure, web-based, end-user password reset management and single sign-on solution that helps domain users to perform self-service password reset, self-service account unlock, employee self-update of personal details (e.g., mobile numbers and photos) in Microsoft Windows Active Directory.

Zoho ManageEngine ADSelfService Plus has Authentication Bypass Vulnerability

Affected Version:
Zoho ManageEngineADSelfService Plus upto build 6113

QID Detection Logic (Authenticated):
Checks for vulnerable version of ManageEngine ADSelfService Plus upto build 6113

This vulnerability allows an attacker to gain unauthorized access to the product through REST API endpoints by sending a specially crafted request. This would allow the attacker to carry out subsequent attacks resulting in RCE.

CVSS V3 rated as Critical - 8.3 severity.

CVSS V2 rated as Critical - 9.7 severity.

Solution

The vendor has released a patch.
Customers are advised to visit release-notes for updates pertaining this vulnerability.

Vendor References

ADSelfService Plus - www.manageengine.com/products/self-service-password/kb/how-to-fix-authentication-bypass-vulnerability-in-REST-API.html

CVEs related to QID 375840

CVE-2021-40539 |

Software Advisories

Advisory ID	Software	Component	Link
ADSelfService Plus			www.manageengine.com/products/self-service-password/kb/how-to-fix-authentication-bypass-vulnerability-in-REST-API.html

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].